← All companies

CGON

CG Oncology, Inc.

CGON Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$69.15

-3.88 -5.31%

Key statistics

from XBRL data in SEC filings

Market cap

$6.10B

Revenue (TTM)

$5.07M

Net income (TTM)

-$187M

EPS (TTM)

$-2.34

P/E ratio

—

Dividend yield

—

Free cash flow

-$132M

Cash

$33.7M

Total assets

$1.14B

Gross margin

—

52-week range

$23.65 – $77.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 8, 2026 8-K Director or officer change May 26, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 8, 2026 8-K Director or officer change Apr 13, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Results of operations (earnings release) Feb 27, 2026 8-K Other events Jan 13, 2026 8-K Regulation FD disclosure; Other events Jan 9, 2026 8-K Director or officer change Nov 26, 2025 8-K Director or officer change Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Regulation FD disclosure Sep 9, 2025 8-K Regulation FD disclosure; Other events Sep 5, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Aug 8, 2025 8-K Director or officer change Jul 11, 2025 8-K Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Regulation FD disclosure; Other events Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release) Mar 28, 2025 8-K Regulation FD disclosure; Other events Mar 24, 2025 8-K Director or officer change Jan 10, 2025 8-K Regulation FD disclosure; Other events Dec 5, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Regulation FD disclosure; Other events May 24, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Other events May 3, 2024 10-K Fiscal year ended 2023-12-31 Mar 26, 2024 8-K Director or officer change Feb 16, 2024 8-K Amended charter or bylaws; Other events Jan 30, 2024

Other filings

144 Jul 29, 2026 144 Jul 28, 2026